slotkoers
Korea S.E.
00:00:00 03-07-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
3.295
KRW
|
-4,77%
|
|
+4,27%
|
+9,83%
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Marktkapitalisatie
1 |
101.388
|
249.937
|
296.774
|
186.048
|
149.085
|
144.635
|
Bedrijfswaarde
1 |
92.027
|
222.135
|
314.521
|
206.108
|
181.558
|
168.530
|
K/w-verhouding
|
-10,7
x
|
-7,86
x
|
-6,31
x
|
-2,57
x
|
-3,6
x
|
-42,6
x
|
Dividendrendement
|
-
|
-
|
-
|
-
|
-
|
-
|
Marktkapitalisatie/omzet
|
2,2
x
|
5,56
x
|
6,81
x
|
3,22
x
|
2,52
x
|
2,03
x
|
Bedrijfswaarde/omzet
|
2
x
|
4,94
x
|
7,22
x
|
3,57
x
|
3,07
x
|
2,36
x
|
Bedrijfswaarde/EBITDA
|
-6,65
x
|
-331
x
|
-53,7
x
|
-14,7
x
|
-9,39
x
|
21,2
x
|
Bedrijfswaarde/FCF
|
-
|
28.062.515
x
|
-14.917.426
x
|
-7.682.984
x
|
-18.708.537
x
|
-35.384.479
x
|
FCF Yield
|
-
|
0%
|
-0%
|
-0%
|
-0%
|
-0%
|
Price to Book
|
1,57
x
|
2,31
x
|
2,75
x
|
2,19
x
|
1,41
x
|
1,36
x
|
Aantal aandelen (in duizenden)
|
14.082
|
23.860
|
28.130
|
33.981
|
46.809
|
48.212
|
Referentieprijs
2 |
7.200
|
10.475
|
10.550
|
5.475
|
3.185
|
3.000
|
Datum van publicatie
|
18/03/20
|
18/03/20
|
23/03/21
|
22/03/22
|
28/03/23
|
21/03/24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Omzet
1 |
46.003
|
44.953
|
43.592
|
57.730
|
59.067
|
71.318
|
EBITDA
1 |
-13.838
|
-672,1
|
-5.860
|
-14.040
|
-19.339
|
7.937
|
Bedrijfsresultaat (EBIT)
1 |
-16.297
|
-2.789
|
-8.039
|
-19.592
|
-22.982
|
4.709
|
Operationele Marge
|
-35,43%
|
-6,2%
|
-18,44%
|
-33,94%
|
-38,91%
|
6,6%
|
Resultaat voor belastingen (EBT)
1 |
-8.534
|
-22.639
|
-43.822
|
-75.848
|
-37.725
|
-2.158
|
Nettowinst (verlies)
1 |
-8.534
|
-27.998
|
-43.754
|
-69.457
|
-38.462
|
-3.357
|
Nettomarge
|
-18,55%
|
-62,28%
|
-100,37%
|
-120,31%
|
-65,12%
|
-4,71%
|
WPA
2 |
-672,8
|
-1.332
|
-1.671
|
-2.130
|
-885,0
|
-70,35
|
Free Cash Flow
|
-
|
7.916
|
-21.084
|
-26.826
|
-9.705
|
-4.763
|
FCF-marge
|
-
|
17,61%
|
-48,37%
|
-46,47%
|
-16,43%
|
-6,68%
|
Kasstroomconversie (ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
Kasstroomconversie (nettowinst)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
18/03/20
|
18/03/20
|
23/03/21
|
22/03/22
|
28/03/23
|
21/03/24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Nettoschuldpositie
1 |
-
|
-
|
17.747
|
20.060
|
32.473
|
23.894
|
Nettokaspositie
1 |
9.361
|
27.802
|
-
|
-
|
-
|
-
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-3,029
x
|
-1,429
x
|
-1,679
x
|
3,01
x
|
Free Cash Flow
|
-
|
7.916
|
-21.084
|
-26.826
|
-9.705
|
-4.763
|
ROE (netto-inkomsten/eigen vermogen)
|
-
|
-25,5%
|
-40%
|
-71,7%
|
-40,8%
|
-2,13%
|
ROA (netto-inkomsten/totale activa)
|
-
|
-1,31%
|
-2,43%
|
-5,53%
|
-7,53%
|
1,63%
|
Totale activa
1 |
-
|
2.130.766
|
1.797.477
|
1.255.367
|
510.830
|
-205.712
|
Nettoactief per aandeel
2 |
4.596
|
4.525
|
3.832
|
2.505
|
2.261
|
2.205
|
Cashflow per aandeel
2 |
827,0
|
2.380
|
2.287
|
406,0
|
50,20
|
169,0
|
Capex
1 |
1.500
|
212
|
869
|
10.111
|
6.491
|
4.523
|
Capex/omzet
|
3,26%
|
0,47%
|
1,99%
|
17,52%
|
10,99%
|
6,34%
|
Datum van publicatie
|
18/03/20
|
18/03/20
|
23/03/21
|
22/03/22
|
28/03/23
|
21/03/24
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| +9,83% | 119 mln. | | +54,07% | 816 mld. | | +38,59% | 634 mld. | | -7,05% | 351 mld. | | +15,44% | 323 mld. | | +5,72% | 293 mld. | | +13,40% | 238 mld. | | +0,61% | 222 mld. | | +13,24% | 218 mld. | | +7,42% | 167 mld. |
Farmaceutische producten - Andere
|